Morton Freytag
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.
Journal: Diagnostics (Basel, Switzerland)
Published: February 16, 2026
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Journal: Experimental and molecular pathology
Published: July 23, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.
Journal: Diagnostics (Basel, Switzerland)
Published: April 11, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.
Journal: Cancers
Published: February 03, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.
Journal: PloS one
Published: December 11, 2024
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes.
Journal: Annals of diagnostic pathology
Published: December 09, 2024
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities.
Journal: Human pathology
Published: December 02, 2024
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: November 29, 2024
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors.
Journal: Virchows Archiv : an international journal of pathology
Published: November 22, 2024
Last Updated: 09/26/2026